Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 2
Technical expert panel for Medicare urological/ostomy supply review
Requires the government to create a technical expert panel to review how Medicare's competitive bidding program affects urological and ostomy supplies, and mandates that the program be run in line with the panel's recommendations, with all findings made public. Directs the government to run a limited test program in up to three states to see how including urological and ostomy supplies in Medicare's competitive bidding system affects patient access and health outcomes, with required surveys of affected patients. Prohibits Medicare contract suppliers from pressuring or persuading patients to switch the brand of urological or ostomy supplies chosen by their doctor, and requires the government to ensure patients can keep accessing the same or comparable supplies even after competitive bidding rules change.
- Population Scope Low Directly affects the narrow population of Medicare beneficiaries using urological or ostomy supplies, plus clinicians, suppliers, and reimbursement experts engaged with those products — well under 10% of the U.S. population.
- Budgetary Magnitude Low No funds are authorized or appropriated; the panel, demonstration project, and surveys draw on existing Department of Health and Human Services (HHS) administrative capacity with no specified dollar obligation.
- Legal / Regulatory Depth High Creates multiple new statutory mandates — a binding expert panel whose recommendations the Secretary of Health and Human Services must follow, a structured demonstration program, enforceable patient protections against supplier coercion, and a guaranteed right of access to comparable supplies — collectively restructuring how the competitive acquisition program operates for this product category.
- Degree of Discretion Granted Medium Panel establishment, demonstrations, and patient-access processes are all mandatory ('shall'), but the Secretary of Health and Human Services retains discretion in selecting demonstration states, designing survey methodology, and determining clinical comparability of supplies.
- Implementation & Enforcement Burden Medium Imposes recurring administrative obligations — constituting a multi-stakeholder panel, conducting beneficiary surveys, running a multi-state demonstration, establishing a supply-access process, and publicly posting all panel documentation — that collectively require sustained new agency infrastructure.
- Temporal Commitment High The patient access guarantee, supplier prohibition, and Secretary's obligation to implement the program consistent with panel recommendations carry no expiry date and persist indefinitely until Congress acts to repeal them.
No signal yet
Carve-outs, Exemptions, Eligibility Top 2
Exclude urological/ostomy supplies from Medicare competitive bidding
Removes urological and ostomy supplies from Medicare's competitive bidding (CB) program for five years, so reimbursement rates for these supplies will not be set through the CB process during that window.
- Population Scope Low Directly affects Medicare beneficiaries who use urological or ostomy supplies and their suppliers — a small, clinically specific subset of the U.S. population well under 10%.
- Budgetary Magnitude Medium Removing these supplies from competitive bidding will likely increase Medicare reimbursement rates above what CB would have set, creating recurring mandatory spending impact over five years, though no specific dollar amount is authorized or appropriated.
- Legal / Regulatory Depth High Creates a new statutory exclusion in the Social Security Act that overrides an existing program mechanism, a substantive legal change that alters binding payment law for a defined product category.
- Degree of Discretion Granted Low The exclusion is mandatory and self-executing, leaving the Department of Health and Human Services (HHS) no discretion over whether or when to apply it.
- Implementation & Enforcement Burden Low Operates as a passive statutory exclusion requiring no new enforcement infrastructure — Centers for Medicare & Medicaid Services (CMS) simply does not apply CB rules to these supplies during the window.
- Temporal Commitment Low Hard expiry on December 31, 2032, self-terminates within ten years unless Congress affirmatively extends it.
No signal yet
No possible riders have been surfaced for this bill.
Summary
This bill changes how Medicare handles payment and access for urological and ostomy supplies. It temporarily removes these supplies from Medicare's competitive bidding (CB) system, creates an expert panel to study the issue, and launches a test program in a small number of states. Among other elements, the bill * blocks CB from applying to urological and ostomy supplies through the end of 2032; * creates a technical expert panel to review how CB affects these supplies and requires the government to follow the panel's recommendations; * funds a small demonstration project in up to three states to test how CB could work for these supplies; * bans suppliers from pressuring patients to switch brands chosen by their doctor; * and guarantees patients the right to keep accessing the same or comparable supplies they had before CB rules changed.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Oct 9, 2026
|
Oct 9, 2026 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 2
Technical expert panel for Medicare urological/ostomy supply review
Requires the government to create a technical expert panel to review how Medicare's competitive bidding program affects urological and ostomy supplies, and mandates that the program be run in line with the panel's recommendations, with all findings made public. Directs the government to run a limited test program in up to three states to see how including urological and ostomy supplies in Medicare's competitive bidding system affects patient access and health outcomes, with required surveys of affected patients. Prohibits Medicare contract suppliers from pressuring or persuading patients to switch the brand of urological or ostomy supplies chosen by their doctor, and requires the government to ensure patients can keep accessing the same or comparable supplies even after competitive bidding rules change.
- Population Scope Low Directly affects the narrow population of Medicare beneficiaries using urological or ostomy supplies, plus clinicians, suppliers, and reimbursement experts engaged with those products — well under 10% of the U.S. population.
- Budgetary Magnitude Low No funds are authorized or appropriated; the panel, demonstration project, and surveys draw on existing Department of Health and Human Services (HHS) administrative capacity with no specified dollar obligation.
- Legal / Regulatory Depth High Creates multiple new statutory mandates — a binding expert panel whose recommendations the Secretary of Health and Human Services must follow, a structured demonstration program, enforceable patient protections against supplier coercion, and a guaranteed right of access to comparable supplies — collectively restructuring how the competitive acquisition program operates for this product category.
- Degree of Discretion Granted Medium Panel establishment, demonstrations, and patient-access processes are all mandatory ('shall'), but the Secretary of Health and Human Services retains discretion in selecting demonstration states, designing survey methodology, and determining clinical comparability of supplies.
- Implementation & Enforcement Burden Medium Imposes recurring administrative obligations — constituting a multi-stakeholder panel, conducting beneficiary surveys, running a multi-state demonstration, establishing a supply-access process, and publicly posting all panel documentation — that collectively require sustained new agency infrastructure.
- Temporal Commitment High The patient access guarantee, supplier prohibition, and Secretary's obligation to implement the program consistent with panel recommendations carry no expiry date and persist indefinitely until Congress acts to repeal them.
No signal yet
Core Policy Mechanism
Technical expert panel for Medicare urological/ostomy supply review
Carve-outs, Exemptions, Eligibility Top 2
Exclude urological/ostomy supplies from Medicare competitive bidding
Removes urological and ostomy supplies from Medicare's competitive bidding (CB) program for five years, so reimbursement rates for these supplies will not be set through the CB process during that window.
- Population Scope Low Directly affects Medicare beneficiaries who use urological or ostomy supplies and their suppliers — a small, clinically specific subset of the U.S. population well under 10%.
- Budgetary Magnitude Medium Removing these supplies from competitive bidding will likely increase Medicare reimbursement rates above what CB would have set, creating recurring mandatory spending impact over five years, though no specific dollar amount is authorized or appropriated.
- Legal / Regulatory Depth High Creates a new statutory exclusion in the Social Security Act that overrides an existing program mechanism, a substantive legal change that alters binding payment law for a defined product category.
- Degree of Discretion Granted Low The exclusion is mandatory and self-executing, leaving the Department of Health and Human Services (HHS) no discretion over whether or when to apply it.
- Implementation & Enforcement Burden Low Operates as a passive statutory exclusion requiring no new enforcement infrastructure — Centers for Medicare & Medicaid Services (CMS) simply does not apply CB rules to these supplies during the window.
- Temporal Commitment Low Hard expiry on December 31, 2032, self-terminates within ten years unless Congress affirmatively extends it.
No signal yet
Carve-outs, Exemptions, Eligibility
Exclude urological/ostomy supplies from Medicare competitive bidding
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: